The relevance of increased sEV secretion in GBM was further supported by the observation that elevated expression of canonical EV markers (ALIX, CD9, CD63, CD81, CD151 and TSG101) correlated with a poorer GBM patient survival (Fig. S1). This evidence concerns the gene TSG101 and glioblastoma.